Electronics & SemiconductorTop Companies
Electronics & Semiconductor

Top Cold Chain Supply Logistics Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Electronics & Semiconductor

Published

Feb 2026

Share:

Electronics & Semiconductor

Top Cold Chain Supply Logistics Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
420.00 Billion
2026 Forecast (US$)
479.60 Billion
2032 Forecast (US$)
1066.00 Billion
CAGR (2025-2032)
14.20%

Summary

The Cold Chain Supply Logistics market is scaling rapidly as pharma, food, and biotech demand tighter temperature control and traceability. Leading Cold Chain Supply Logistics market companies consolidate share through global networks, automation, and GDP-compliant services. The market grows from US$ 420.00 Billion in 2025 to US$ 1,066.00 Billion by 2032, reflecting a robust 14.20% CAGR.

2025 Revenue of Top Cold Chain Supply Logistics Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

The rankings of Cold Chain Supply Logistics market companies are derived from a composite score blending quantitative and qualitative metrics. Core inputs include estimated 2025 cold-chain logistics revenue, multi-year contract backlog, and the scale of temperature-controlled warehousing and transport fleets. We also assess technology differentiation in real-time monitoring, IoT telematics, packaging innovation, and GDP/ISO certifications. Portfolio breadth across pharma, vaccines, biopharma, fresh and frozen foods, and specialty chemicals is weighted, alongside geographic service coverage and multimodal capabilities. Strategic criteria encompass M&A activity, green logistics investments, digital platforms, and ability to execute long-term, validated lane and maintenance contracts. Scores are normalised regionally and globally, triangulated with public disclosures, third‑party databases, and expert interviews to reduce bias and reflect the sustainable competitive position of each player.

Top 10 Companies in Cold Chain Supply Logistics

1
DHL Supply Chain & Global Forwarding (Deutsche Post DHL Group)
Pharmaceuticals, vaccines, clinical trials, fresh and frozen food, healthcare devices.
Bonn, Germany
Operations in more than 220 countries and territories with dense cold chain networks in Europe, North America, and Asia Pacific.
GDP-compliant pharma hubs, multi-temperature warehouses, cross-docking platforms, and specialized life-sciences transport fleet.
IoT-based temperature monitoring, control towers, digital twin lane validation, advanced data analytics.
Market leader leveraging scale, integrated forwarding and contract logistics, and strong quality certifications to win global key accounts.
Expanded pharma hubs in Singapore and Belgium, launched carbon-neutral cold chain products, acquired regional cold storage assets.
US$ 18.50 Billion
2
Kuehne+Nagel International AG
Biopharma, vaccines, healthcare, fresh produce, meat and seafood.
Schindellegi, Switzerland
Strong presence across Europe, North America, and Asia with extensive seafreight and airfreight cold chain capacity.
Pharma-grade warehouses, validated packaging network, refrigerated cross-docks and last-mile partnerships.
KN PharmaChain platform, real-time shipment visibility, lane risk assessment, compliant documentation workflows.
Top-tier integrator known for quality, reliability, and deep healthcare vertical expertise in global cold chain logistics.
Invested in additional pharma hubs in the U.S. and India, expanded control tower network, strengthened sustainability reporting.
US$ 13.20 Billion
3
UPS Healthcare (United Parcel Service, Inc.)
Pharma, vaccines, medical devices, clinical trials, specialty pharma home delivery.
Atlanta, USA
High density distribution in North America and Europe, growing footprint in Asia and Latin America.
Specialized healthcare campuses, temperature-controlled hubs, last-mile cold chain network with parcel integration.
Integrated cold chain visibility, shipment orchestration, predictive risk alerts, advanced packaging engineering.
Integrator of parcel, freight, and healthcare logistics delivering end-to-end temperature-controlled solutions at global scale.
Expanded UPS Premier, added new healthcare facilities in Italy and Australia, strengthened biologics distribution capabilities.
US$ 11.80 Billion
4
FedEx Logistics & FedEx Express Healthcare
Biologics, vaccines, time-critical diagnostics, high-value food shipments.
Memphis, USA
Global air express network with strong coverage in North America, Europe, and key Asian trade lanes.
Cold chain-enabled hubs, temperature-controlled containers, healthcare-focused distribution centers.
SenseAware monitoring, priority alert services, shipment visibility dashboards, exception management tools.
Strong in time-definite, high-value cold chain shipments leveraging proprietary air network and specialized monitoring solutions.
Upgraded temperature-controlled capacity at major hubs, expanded healthcare vertical sales, piloted low-carbon aviation fuel routes.
US$ 9.40 Billion
5
Lineage Logistics Holdings, LLC
Frozen and chilled foods, retail grocery, foodservice, food manufacturers.
Novi, USA
Extensive presence across North America and Europe, expanding into Asia Pacific and Latin America.
Massive cold storage warehouse network, automated high-bay facilities, port-adjacent terminals.
Warehouse automation, energy optimization, digital inventory management, integrated transport orchestration.
Dominant temperature-controlled warehousing specialist with growing ambitions in integrated cold chain solutions.
Acquired regional cold storage operators, invested in robotics and AS/RS, expanded port warehousing capacity.
US$ 8.70 Billion
6
Americold Realty Trust, Inc.
Packaged foods, meat, poultry, seafood, retail grocery chains.
Atlanta, USA
Network concentrated in North America with select sites in Europe and Asia Pacific.
Large cold storage portfolio, rail-connected sites, value-added services at distribution centers.
Warehouse management systems, slotting optimization, energy-efficient refrigeration systems.
Key cold storage REIT focusing on integrated warehousing and transportation offerings to secure long-term customer relationships.
Expanded automation projects, executed long-term contracts with major food brands, divested non-core assets.
US$ 7.10 Billion
7
C.H. Robinson Worldwide, Inc. (Temp-Controlled Services)
Food and beverage, retail, quick-service restaurants, some healthcare freight.
Eden Prairie, USA
North American strength with growing international cold chain brokerage and managed services.
Asset-light carrier network, contracted refrigerated fleets, temperature-controlled consolidation centers.
Navisphere platform, real-time temperature and location tracking, analytics for lane optimization.
Leading 3PL using scale and technology to orchestrate multi-carrier temperature-controlled transport solutions.
Expanded reefer carrier base, launched enhanced cold chain visibility tools, increased focus on cross-border Mexico trade.
US$ 6.30 Billion
8
Maersk (A.P. Moller - Maersk A/S) Cold Chain Logistics
Fruits, vegetables, meat, seafood, pharmaceuticals via integrated logistics solutions.
Copenhagen, Denmark
Global ocean network with strong Asia-Europe, Latin America-Europe, and Asia-North America cold corridors.
Large reefer container fleet, inland cold warehouses, integrated port logistics and intermodal connections.
Remote container management, digital booking platforms, supply chain visibility tools.
Integrated ocean and logistics provider turning reefer dominance into door-to-door cold chain offerings.
Invested in inland cold stores, expanded integrated cold chain solutions in India and Latin America, added eco-efficient reefers.
US$ 5.90 Billion
9
Nippon Express Holdings, Inc. (NX Group)
Pharmaceuticals, high-value foods, electronics requiring controlled environments.
Tokyo, Japan
Strong presence in Japan and Asia, growing in Europe and North America via acquisitions and partnerships.
Pharma-certified warehouses, airport-adjacent cold facilities, specialized domestic distribution network.
Validated cold chain lanes, compliance documentation systems, real-time tracking for pharma shipments.
Regionally strong Asian player transitioning into a global healthcare and cold chain logistics specialist.
Strengthened European pharma logistics, invested in new cold warehouses in Japan and Southeast Asia, expanded GDP certifications.
US$ 5.10 Billion
10
DB Schenker (Deutsche Bahn Group)
Healthcare, food and beverage, retail, industrial temperature-sensitive goods.
Essen, Germany
Pan-European network with global air and ocean forwarding capabilities.
Temperature-controlled terminals, pharma-certified warehouses, multimodal cold chain corridors.
Visibility platforms, lane risk tools, e-booking and track-and-trace for temperature-sensitive freight.
Important European-based cold chain forwarder leveraging rail and road strengths to provide multimodal solutions.
Expanded healthcare logistics footprint in Europe, piloted low-emission reefer trucks, improved pharma quality systems.
US$ 4.80 Billion

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

DHL Supply Chain & Global Forwarding (Deutsche Post DHL Group)

Global leader offering end-to-end temperature-controlled logistics for pharmaceuticals, vaccines, clinical trials, and perishable foods across all major trade lanes.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 18.50 Billion; estimated cold chain revenue CAGR 2025-2032 at 13.50%.
Flagship Products: DHL Life Sciences & Healthcare, DHL PharmaCool, DHL FoodLogistics
2025-2026 Actions: Opened new GDP-compliant pharma hubs, scaled IoT monitoring, and deepened partnerships with leading vaccine manufacturers.
Three-line SWOT: Unmatched global network and certifications; Complex organization can slow bespoke solution design; Opportunity—sharper focus on integrated digital cold chain platforms.
Notable Customers: Pfizer, Nestlé, Novartis
2

Kuehne+Nagel International AG

Top-tier global logistics provider specializing in pharma and fresh food cold chain with strong seafreight and airfreight capabilities.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 13.20 Billion; operating margin in healthcare and pharma segment estimated at 11.20%.
Flagship Products: KN PharmaChain, KN FreshChain, KN Sea-Air cold solutions
2025-2026 Actions: Expanded pharma hubs in the U.S. and India, invested in lane validation tools, and enhanced sustainability reporting for healthcare customers.
Three-line SWOT: Deep healthcare expertise and strong seafreight position; Comparatively lower penetration in last-mile healthcare; Opportunity—growth in biologics and complex therapies distribution.
Notable Customers: Roche, GSK, Chiquita Brands
3

UPS Healthcare (United Parcel Service, Inc.)

Integrated parcel and freight operator providing specialized healthcare cold chain services, including biologics and home delivery for specialty therapies.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 11.80 Billion; UPS Healthcare revenue share of total UPS estimated at 16.40%.
Flagship Products: UPS Premier, UPS Temperature True, UPS Healthcare logistics campuses
2025-2026 Actions: Added healthcare facilities in Europe and APAC, scaled UPS Premier tracking, and strengthened partnerships with biotech innovators.
Three-line SWOT: Parcel network integration and strong healthcare brand; Exposure to parcel volume cycles; Opportunity—expanding direct-to-patient cold chain services.
Notable Customers: Moderna, Johnson & Johnson, Abbott Laboratories
4

FedEx Logistics & FedEx Express Healthcare

Global express giant focused on time-critical, high-value cold chain shipments supported by proprietary monitoring solutions.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 9.40 Billion; healthcare and cold chain volumes growing at an estimated 12.80% annually.
Flagship Products: FedEx Priority Alert, SenseAware, FedEx Cold Shipping Solutions
2025-2026 Actions: Upgraded cold chain capacity at key air hubs, promoted premium monitoring offerings, and piloted low-carbon aviation fuel for select routes.
Three-line SWOT: Strong express network and monitoring tech; Higher cost base in commoditized lanes; Opportunity—premiumization of monitored cold chain for biologics.
Notable Customers: Bristol Myers Squibb, Quest Diagnostics, Dole Food Company
5

Lineage Logistics Holdings, LLC

Major temperature-controlled warehousing specialist evolving into an integrated cold chain solutions provider for global food brands and retailers.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 8.70 Billion; automated facilities share of portfolio expected to exceed 32.00% by 2030.
Flagship Products: Automated high-bay warehouses, port-centric cold terminals, integrated transport management services
2025-2026 Actions: Acquired regional cold storage operators, invested in robotics and AS/RS systems, and expanded capacity at strategic ports.
Three-line SWOT: Massive warehouse footprint and automation capabilities; Limited pharma exposure; Opportunity—expanding value-added services and integrated food chain offerings.
Notable Customers: Tyson Foods, Walmart, McCain Foods
6

Americold Realty Trust, Inc.

Leading cold storage REIT operating large temperature-controlled warehouses serving big food manufacturers and retailers in North America and beyond.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 7.10 Billion; occupancy rates in core facilities typically above 80.00%.
Flagship Products: Integrated warehousing and transportation, value-added food processing services, rail-connected distribution hubs
2025-2026 Actions: Accelerated automation in key sites, renewed multi-year agreements with major food brands, and exited non-core facilities to optimise portfolio.
Three-line SWOT: Strong North American footprint and REIT capital access; Concentrated exposure to food cycles; Opportunity—further penetration into e-grocery cold chain.
Notable Customers: Conagra Brands, Kroger, General Mills
7

C.H. Robinson Worldwide, Inc. (Temp-Controlled Services)

Asset-light 3PL orchestrating large networks of refrigerated carriers and providing technology-enabled cold chain managed services.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 6.30 Billion; digital bookings via Navisphere covering over 65.00% of reefer shipments.
Flagship Products: Temp-Controlled Truckload, Cold LTL consolidation, Managed cold chain services
2025-2026 Actions: Expanded reefer carrier network, enhanced visibility tools, and deepened cross-border U.S.-Mexico cold chain capabilities.
Three-line SWOT: Flexible, tech-driven model and large carrier base; Limited owned infrastructure; Opportunity—outsourced cold chain control towers for retail and foodservice.
Notable Customers: McDonald’s, Sysco, PepsiCo
8

Maersk (A.P. Moller - Maersk A/S) Cold Chain Logistics

Integrated container shipping and logistics company leveraging reefer dominance to offer door-to-door cold chain solutions.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 5.90 Billion; reefer container fleet exceeding 1,00,000 units worldwide.
Flagship Products: Maersk Cold Chain Logistics, remote reefer management, inland cold storage and distribution
2025-2026 Actions: Invested in inland cold warehouses, expanded offerings in India and Latin America, and deployed more energy-efficient reefers.
Three-line SWOT: Global ocean scale and reefer expertise; Dependence on trade flows; Opportunity—capturing more inland value with integrated cold chain services.
Notable Customers: Del Monte, JBS, Driscoll’s
9

Nippon Express Holdings, Inc. (NX Group)

Japan-based logistics group with growing international presence in pharma and sensitive goods cold chain transportation.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 5.10 Billion; healthcare logistics business growing at about 14.00% annually.
Flagship Products: NX Pharma Logistics, temperature-controlled air freight, domestic refrigerated distribution
2025-2026 Actions: Expanded GDP-certified facilities, strengthened European pharma logistics, and added cold warehouses in Japan and Southeast Asia.
Three-line SWOT: Strong Asian network and pharma know-how; Less scale in Americas; Opportunity—leveraging Japanese quality reputation for global pharma contracts.
Notable Customers: Takeda, Daiichi Sankyo, Aeon Retail
10

DB Schenker (Deutsche Bahn Group)

Global logistics provider with strong European base offering multimodal temperature-controlled services for healthcare and food.

Key Financials: 2025 Cold Chain Supply Logistics revenue US$ 4.80 Billion; European cold chain revenue share estimated at 70.00% of segment total.
Flagship Products: Schenker Pharma Logistics, multimodal cold chain corridors, temperature-controlled terminals
2025-2026 Actions: Expanded healthcare logistics in Europe, invested in low-emission reefer trucks, and upgraded quality systems for pharma operations.
Three-line SWOT: European network and rail integration; More limited cold chain footprint in Americas; Opportunity—leveraging sustainability leadership for pharma tenders.
Notable Customers: Bayer, Sanofi, Aldi

SWOT Leaders

DHL Supply Chain & Global Forwarding (Deutsche Post DHL Group)

SWOT Snapshot

SWOT
Strengths

Unrivalled global footprint, dense pharma and food networks, strong compliance culture, and advanced IoT-driven visibility platforms.

Weaknesses

Organisational complexity and global scale can slow bespoke solution development and pricing agility in emerging markets.

Opportunities

Rising demand for integrated digital cold chain platforms, biologics growth, and sustainability-focused contracts with large healthcare clients.

Threats

Intensifying competition from asset-light specialists, regional champions, and potential regulatory tightening across multiple jurisdictions.

Kuehne+Nagel International AG

SWOT Snapshot

SWOT
Strengths

Deep healthcare and fresh food domain expertise, strong seafreight and airfreight networks, and proven KN PharmaChain platform.

Weaknesses

Relatively modest last-mile cold chain capabilities compared with integrators tightly owning parcel networks.

Opportunities

Biologics, cell and gene therapies, and emerging-market healthcare infrastructure investments requiring sophisticated cold chain solutions.

Threats

Price competition on commoditized reefer lanes and potential modal shifts driven by regionalisation of manufacturing footprints.

UPS Healthcare (United Parcel Service, Inc.)

SWOT Snapshot

SWOT
Strengths

Integrated parcel and freight network, advanced UPS Premier tracking, and established brand trust with global pharma clients.

Weaknesses

Exposure to overall parcel demand cycles and high fixed-cost infrastructure in slower-growth regions.

Opportunities

Direct-to-patient specialty therapies, home healthcare, and expanding biologics distribution in high-growth emerging markets.

Threats

Competition from specialized healthcare 3PLs and regulatory changes in home delivery of controlled medical products.

Cold Chain Supply Logistics Market Regional Competitive Landscape

North America remains the most mature cold chain region, driven by stringent FDA regulations, concentrated food retail, and advanced healthcare ecosystems. DHL, UPS Healthcare, FedEx, Lineage Logistics, Americold, and C.H. Robinson dominate, while Cold Chain Supply Logistics market companies compete aggressively on network density, automation, and end-to-end visibility for pharma, biologics, and omnichannel grocery.

Europe exhibits strong regulatory oversight, with GDP and food safety standards pushing Cold Chain Supply Logistics market companies toward high-quality, certified networks. DHL, Kuehne+Nagel, DB Schenker, Maersk, and Lineage are prominent. Growth is fuelled by cross-border pharma flows, discount grocery expansion, and sustainability mandates favouring rail and low-emission multimodal corridors.

Asia Pacific is the fastest-growing arena, underpinned by rising middle-class consumption, vaccine manufacturing, and food import dependencies. Global leaders like DHL, Kuehne+Nagel, UPS Healthcare, and Maersk compete with regional players such as Nippon Express. Investments prioritise greenfield cold warehouses, port-centric hubs, and digitally monitored reefer corridors linking producers with urban megacities.

Latin America presents high growth but operational complexity, with infrastructure gaps and regulatory variability. Maersk, DHL, Kuehne+Nagel, and regional specialists expand reefer capacity for meat, fruits, and pharmaceuticals. Cold Chain Supply Logistics market companies emphasise risk mitigation, lane validation, and collaborative investment with exporters to stabilise service quality and reduce spoilage.

The Middle East and Africa region is emerging as a strategic transit and distribution hub, especially for vaccines, specialty pharma, and high-value foods. Gulf states invest in airport-centric pharma hubs and advanced cold storage. DHL, Kuehne+Nagel, UPS Healthcare, and regional players compete to anchor corridors connecting Europe, Asia, and African growth markets.

Intra-regional trade and nearshoring trends are reshaping network design worldwide. Cold Chain Supply Logistics market companies shift from purely global lanes toward resilient regional ecosystems with redundancy and multi-node storage. Leaders such as DHL, UPS, and Maersk redesign footprints to balance cost, service, and risk across diversified, digitally orchestrated cold chain networks.

Cold Chain Supply Logistics Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

CryoTrack Analytics
Disruptor
USA

Cloud-native platform that integrates multi-vendor sensors to deliver lane-level predictive risk scoring for Cold Chain Supply Logistics market companies.

CoolKart Last Mile
Disruptor
India

Asset-light urban micro-fulfilment and refrigerated two-wheeler network targeting e-grocery and pharmacy deliveries in congested megacities.

PolarCube Containers
Disruptor
Germany

Develops reusable, battery-assisted passive containers with embedded IoT, cutting packaging waste and energy costs for sensitive shipments.

BioThermo Express
Disruptor
United Kingdom

Specialised courier using small-format, actively controlled shippers for cell and gene therapy logistics with strict chain-of-custody protocols.

Andes FreshChain
Disruptor
Chile

Regional integrator combining refrigerated trucking, cross-docks, and SaaS visibility tailored to fruit exporters serving global retail buyers.

SaharaCool Logistics
Disruptor
United Arab Emirates

Temperature-controlled logistics provider leveraging solar-powered depots and desert-optimised reefers for GCC and Africa-bound pharma and food flows.

Cold Chain Supply Logistics Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Cold Chain Supply Logistics market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Cold Chain Supply Logisticsmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.